Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 112 results:
Συντάκτης Τίτλος [ Τύπος(Desc)] Έτος
Φίλτρα: Συντάκτης is Anagnostis, Panagiotis  [Clear All Filters]
Journal Article
Gotsis, E., Anagnostis P., Mariolis A., Vlachou A., Katsiki N., & Karagiannis A. (2015).  Health benefits of the Mediterranean Diet: an update of research over the last 5 years.. Angiology. 66(4), 304-18.
Anagnostis, P., Paschou S. A., Kenanidis E., Lambrinoudaki I., Potoupnis M., Tsiridis E., et al. (2019).  "Holidays" for osteoporosis drugs: A case-based approach.. Case Rep Womens Health. 23, e00127.
Anagnostis, P., Vakalopoulou S., Slavakis A., Simoulidou E., Rakitzi P., Garipidou V., et al. (2009).  Hypoglycemia in a patient with advanced Sezary syndrome.. Leuk Lymphoma. 50(2), 284-6.
Athyros, V. G., Tziomalos K., Katsiki N., Gossios T. D., Giouleme O., Anagnostis P., et al. (2013).  The impact of smoking on cardiovascular outcomes and comorbidities in statin-treated patients with coronary artery disease: a post hoc analysis of the GREACE study.. Curr Vasc Pharmacol. 11(5), 779-84.
Anagnostis, P., Athyros V. G., Karagiannis A., & Mikhailidis D. P. (2011).  Impact of statins on glucose metabolism--a matter of debate.. Am J Cardiol. 107(12), 1866.
Paschou, S. A., Anagnostis P., Goulis D. G., Siasos G., & Vryonidou A. (2018).  Letter to the Editor: "Androgens, Irregular Menses, and Risk of Diabetes and Coronary Artery Calcification in the Diabetes Prevention Program".. J Clin Endocrinol Metab. 103(5), 2066-2067.
Anagnostis, P., & Goulis D. G. (2019).  Letter to the Editor: "Familial Hypercholesterolemia and Risk of Peripheral Arterial Disease and Chronic Kidney Disease".. J Clin Endocrinol Metab. 104(8), 3124.
Anagnostis, P., Kenanidis E., Potoupnis M., Tsiridis E., & Goulis D. G. (2020).  Letter to the Editor: "Pharmacological Management of Osteoporosis in Postmenopausal Women: an Endocrine Society Clinical Practice Guideline".. J Clin Endocrinol Metab. 105(1), 
Anagnostis, P., Karras S., Lambrinoudaki I., Stevenson J. C., & Goulis D. G. (2016).  Lipoprotein(a) in postmenopausal women: assessment of cardiovascular risk and therapeutic options.. Int J Clin Pract. 70(12), 967-977.
Anagnostis, P., Adamidou F., Polyzos S. A., Efstathiadou Z., Karathanassi E., & Kita M. (2012).  Long term follow-up of patients with prolactinomas and outcome of dopamine agonist withdrawal: a single center experience.. Pituitary. 15(1), 25-9.
Anagnostis, P., Paschou S. A., & Goulis D. G. (2018).  Management of Acute Hip Fracture.. N Engl J Med. 378(10), 971-2.
Anagnostis, P., Vaitsi K., Veneti S., Georgiou T., Paschou S. A., Lambrinoudaki I., et al. (2019).  Management of dyslipidaemias in the elderly population-A narrative review.. Maturitas. 124, 93-99.
Karras, S. N., Anagnostis P., Petroczi A., Annweiler C., Naughton D. P., & Goulis D. P. (2015).  Maternal vitamin D status in pregnancy: a critical appraisal of current analytical data on maternal and neonatal outcomes.. Hormones (Athens). 14(2), 224-31.
Anagnostis, P., Paschou S. A., Katsiki N., Krikidis D., Lambrinoudaki I., & Goulis D. G. (2019).  Menopausal Hormone Therapy and Cardiovascular Risk: Where are we Now?. Curr Vasc Pharmacol. 17(6), 564-572.
Anagnostis, P., & Goulis D. G. (2019).  Menopause and its Cardiometabolic Consequences: Current Perspectives.. Curr Vasc Pharmacol. 17(6), 543-545.
Anagnostis, P., Bitzer J., Cano A., Ceausu I., Chedraui P., Durmusoglu F., et al. (2020).  Menopause symptom management in women with dyslipidemias: An EMAS clinical guide.. Maturitas. 135, 82-88.
Anagnostis, P., Lambrinoudaki I., Stevenson J. C., & Goulis D. G. (2022).  Menopause-associated risk of cardiovascular disease.. Endocr Connect. 11(4), 
Anagnostis, P., Karras S. N., & Goulis D. G. (2014).  Monitoring the efficacy of once-weekly teriparatide. Are bone turnover markers useful in predicting fracture risk?. Curr Med Res Opin. 30(6), 1177-8.
Mitsiou, E. K., Tziomalos K., Anagnostis P., Karagiannis A., & Athyros V. G. (2009).  Multifactorial intervention for the prevention of vascular complications of type 2 diabetes.. Hellenic J Cardiol. 50(6), 445-8.
Anagnostis, P., Gkekas N. K., Potoupnis M., Kenanidis E., Tsiridis E., & Goulis D. G. (2019).  New therapeutic targets for osteoporosis.. Maturitas. 120, 1-6.
Paschou, S. A., Polyzos S. A., Anagnostis P., Goulis D. G., Kanaka-Gantenbein C., Lambrinoudaki I., et al. (2019).  Nonalcoholic fatty liver disease in women with polycystic ovary syndrome.. Endocrine.
Athyros, V. G., Polyzos S. A., Kountouras J., Katsiki N., Anagnostis P., Doumas M., et al. (2019).  Non-alcoholic fatty liver disease treatment in patients with type 2 diabetes mellitus; new kids on the block.. Curr Vasc Pharmacol.
Anagnostis, P., Vaitsi K., Mintziori G., Goulis D. G., & Mikhailidis D. P. (2020).  Non-coronary atherosclerotic cardiovascular disease in patients with familial hypercholesterolaemia.. Curr Med Res Opin. 1-10.
Polyzos, S. A., Anastasilakis A. D., Anagnostis P., Kita M., Arsos G., Moralidis E., et al. (2012).  Normal bone turnover markers in a patient with active Paget's disease of bone: response to treatment with zoledronic acid.. Endokrynol Pol. 63(4), 312-5.
Katsiki, N., Anagnostis P., Kotsa K., Goulis D. G., & Mikhailidis D. P. (2019).  Obesity, Metabolic Syndrome and the Risk of Microvascular Complications in Patients with Diabetes mellitus.. Curr Pharm Des. 25(18), 2051-2059.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές